Results 91 to 100 of about 1,626 (189)

Antiemetic effect of oral ramosetron in women undergoing thyroidectomy

Korean Journal of Anesthesiology, 2008
Background: Postoperative nausea and vomiting (PONV) after thyroidectomy in women is especially frequent. Ramosetron and dexamethasone prevent cancer chemotherapy-related nausea and vomiting- and PONV. Methods: Ninety three women undergoing thyroidectomy under general anesthesia with sevoflurane and remifentanil were allocated to one of three groups ...
Kwang Yoon, Sie Jeong Ryu, Soo Bong Yu, Se Hwan Kim   +3 more
openaire   +1 more source

Ramosetron for the prevention of nausea and vomiting during 5-fluorouracil-based chemoradiotherapy for pancreatico-biliary cancer

, 2008
OBJECTIVE: The aim of the study was to evaluate the role of ramosetron for the prevention of chemoradiotherapy-induced nausea and vomiting (CRINV) in patients receiving upper abdominal irradiation with concurrent 5-fluorouracil chemotherapy.
Oh, Do-Youn, Ha, Sung W., Jang, Jin-Young, Ha, Sung W, Chie, Eui Kyu, Kim, Tae-You, Kim, Kyubo, Kim, Sun Whe, Im, Seock-Ah, Bang, Yung-Jue, K. Kim, S. W. Ha, Y.-J. Bang, T.-Y. Kim, S. W. Kim, E. K. Chie, D.-Y. Oh, S.-A. Im, J.-Y. Jang   +18 more
core   +1 more source

Ramosetron vs. ramosetron plus dexamethasone for the prevention of postoperative nausea and vomiting (PONV) after laparoscopic cholecystectomy: Prospective, randomized, and double-blind study

International Journal of Surgery, 2013
Up to 75% of the patients undergoing laparoscopic cholecystectomy develop postoperative nausea and vomiting (PONV). Both ramosetron, a serotonin subtype 3 (5-HT3) antagonist, and dexamethasone are effective for PONV prophylaxis following laparoscopic cholecystectomy but their combined effect has not been investigated.
Ryu, Jung-Hee, Chang, Ji-Eun, Kim, Hye-Rim, Hwang, Jung-Won, Oh, Ah-Young, Do, Sang-Hwan   +5 more
openaire   +2 more sources

Guideline for the assessment and management of gastrointestinal symptoms following colorectal surgery—A UEG/ESCP/EAES/ESPCG/ESPEN/ESNM/ESSO collaboration. Part I—Sequelae to oncological diseases

United European Gastroenterology Journal, Volume 12, Issue 10, Page 1489-1506, December 2024.
Anke H. C. Gielen, on behalf ofthe Guideline Development Group, Stavros A. Antoniou, Geerard L. Beets, Stephanie O. Breukink, Suzanne Dore, Asbjørn M. Drewes, Hannah Garside, Marc A. Gladman, Deena Harji, Goran Hauser, Therese Juul, Daniel Keszthelyi, Jos Kleijnen, Christos Kontovounisios, Laura Lorenzon, Lisa Massey, Jarno Melenhorst, Helen M. Mohan, Jean Muris, Coco Smit, Yvonne Tillotson, Arved Weimann, Marco Zelic   +23 more
wiley   +1 more source

Evaluation of efficacy of palonosetron versus ramosetron in patients receiving emetogenic chemotherapy [PDF]

, 2019
Background: Chemotherapy induced nausea and vomiting is the most distressing side effect of cancer chemotherapy. It can seriously impact patient’s quality of life, influence the adherence to chemotherapy and progression free survival causing a delay or ...
Kalshetty, Prakash, Ghazala, Zainab, V., Anuradha H., Zainab Ghazala, Prakash Kalshetty, Anuradha H. V.   +5 more
core   +1 more source

Intravenous palonosetron compared with a combination of ramosetron and dexamethasone in preventing post operative nausea and vomiting in patients undergoing gynaecological surgeries under spinal anaesthesia, a randomised study

Indian Journal of Anaesthesia, 2017
Background and Aims: Post-operative nausea and vomiting (PONV) is one of the most common complications in patients undergoing gynaecological surgeries under spinal anaesthesia (SA).
Archana B Narayanappa, Shivakumar Gurulingaswamy, Umesh N Prabhakaraiah, Somsundar R Gurushanth, Vinay Sapare, Nagaraj Goud   +5 more
doaj   +1 more source

A Comparative study of Ramosetron Versus Ondansetron for Prevention of Postoperative Nausea and Vomiting in patients undergoing laproscopic surgeries under general anaesthesia [PDF]

, 2021
Background: Nausea and vomiting are distressing symptoms after laparoscopic surgeries. Number of drugs is used but none is devoid of side effects. Introduction of 5-HT3 receptors antagonists heralded the major advance in the treatment of postoperative ...
Madiha Shadab, Shafqat Arfin, Rekha Kumari   +2 more
core  

Population pharmacokinetics and prophylactic anti-emetic efficacy of ramosetron in surgical patients

, 2018
AimsThis study characterized the pharmacokinetics of ramosetron and compared prophylactic anti-emetic efficacy with that of ondansetron in a large population.
이은경
core   +2 more sources

Are Solifenacin and Ramosetron Really Ideal to Treat Irritable Bowel Syndrome?

Journal of Neurogastroenterology and Motility, 2012
TO THE EDITOR: Apart from the annoying bowel symptoms, irritable bowel syndrome (IBS) patients usually have various extra-intestinal co-morbidities in terms of insomnia, depression, chronic fatigue syndrome, fibromyalgia, chronic pelvic pain and lower urinary tract symptoms.1,2 Accordingly, a concept of central sensitivity syndromes (CSS) has been ...
openaire   +3 more sources

Is Intravenous Ramosetron 0.3 mg Effective In The Prevention Of Postoperative Nausea And Vomiting In Women Undergoing Gynecologic Surgery? [PDF]

, 2012
OBJECTIVE: The objective of this selective EBM review is to determine whether or not intravenous ramosetron 0.3 mg is effective in the prevention of postoperative nausea and vomiting (PONV) in women undergoing gynecologic surgery. STUDY DESIGN: Review of
Elsner, Keith S
core